Estroqen and risk of gastric cancer: A protective effect in a nationwide cohort study of patients with prostate cancer in Sweden

Cancer Epidemiology Biomarkers and Prevention

Volumn 13, Issue 12, 2004, Pages 2203-2207

  Lindblad, Mats ^a   Ye, Weimin ^b   Rubio, Carlos ^a   Lagergren, Jesper ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER RISK; COHORT ANALYSIS; FEMALE; FOLLOW UP; HEALTH HAZARD; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; PROTECTION; SEX RATIO; STOMACH CANCER; SWEDEN; CARDIA; EPIDEMIOLOGY; PATHOLOGY; PROSTATE TUMOR; REGISTER; RISK FACTOR; SEX DIFFERENCE; STATISTICS; STOMACH TUMOR;

AGED; CARDIA; COHORT STUDIES; EPIDEMIOLOGIC STUDIES; ESTROGENS; HUMANS; MALE; PROSTATIC NEOPLASMS; REGISTRIES; RISK FACTORS; SEX FACTORS; STOMACH NEOPLASMS; SWEDEN;

EID: 11144235655     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Lambert R, Guilloux A, Oshima A, et al. Incidence and mortality from stomach cancer in Japan, Slovenia and the USA. Int J Cancer 2002;97:811-8.
2. Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev 1986;8:1-27.
3. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001;2:533-43.
4. Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. J Clin Epidemiol 2003;56:1-9.
5. Wu AH, Wan P, Bernstein L. A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States). Cancer Causes Control 2001;12:721-32.
6. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-31.
7. Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 1999;130:883-90.
8. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049-53.
9. Farrow DC, Vaughan TL, Sweeney C, et al. Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer. Cancer Causes Control 2000;11:231-8.
10. Kaneko S, Yoshimura T. Time trend analysis of gastric cancer incidence in Japan by histological types, 1975-1989. Br J Cancer 2001;84:400-5.
11. Sipponen P, Correa P. Delayed rise in incidence of gastric cancer in females results in unique sex ratio (M/F) pattern: etiologic hypothesis. Gastric Cancer 2002;5:213-9.
12. Heuch I, Kvale G. Menstrual and reproductive factors and risk of gastric cancer: a Norwegian cohort study. Cancer Causes Control 2000;11:869-74.
13. Palli D, Cipriani F, Decarli A, et al. Reproductive history and gastric cancer among post-menopausal women. Int J Cancer 1994;56:812-5.
14. La Vecchia C, D'Avanzo B, Franceschi S, Negri E, Parazzini F, Decarli A. Menstrual and reproductive factors and gastric-cancer risk in women. Int J Cancer 1994;59:761-4.
15. Kaneko S, Tamakoshi A, Ohno Y, Mizoue T, Yoshimura T. Menstrual and reproductive factors and the mortality risk of gastric cancer in Japanese menopausal females. Cancer Causes Control 2003;14:53-9.
16. Inoue M, Ito LS, Tajima K, et al. Height, weight, menstrual and reproductive factors and risk of gastric cancer among Japanese postmenopausal women: analysis by subsite and histologic subtype. Int J Cancer 2002;97:833-8.
17. Fritjofsson A. Urologi i Sverige 1940-1990. Sydsven Medicinhist Sallsk Arsskr; 1996. p. 155-250.
18. Lagergren J, Nyren O. Do sex hormones play a role in the etiology of esophageal adenocarcinoma? A new hypothesis tested in a population-based cohort of prostate cancer patients. Cancer Epidemiol Biomarkers Prev 1998;7:913-5.
19. Ekstrom AM, Signorello LB, Hansson LE, Bergstrom R, Lindgren A, Nyren O. Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst 1999;91:786-90.
20. Mattsson B, Rutqvist LE, Wallgren A. Undernotification of diagnosed cancer cases to the Stockholm Cancer Registry. Int J Epidemiol 1985;14:64-9.
21. Bailar JI, Ederer F. Significance factors for the ratio of a Poisson variable to its expectation. Biometrics 1964;20:639-43.
22. Alivizatos G, Oosterhof GO. Update of hormonal treatment in cancer of the prostate. Anticancer Drugs 1993;4:301-9.
23. Cox RL, Crawford ED. Estrogens in the treatment of prostate cancer. J Urol 1995;154:1991-8.
24. McLeod DG. Hormonal therapy: historical perspective to future directions. Urology 2003;61:3-7.
25. Rothman KJ. Modern epidemiology. Boston: Little, Brown and Company; 1986.
26. Campbell-Thompson M, Lauwers GY, Reyher KK, Cromwell J, Shiverick KT. 17β-Estradiol modulates gastroduodenal preneoplastic alterations in rats exposed to the carcinogen N-methyl-N′-nitro-nitrosoguanidine. Endocrinology 1999;140:4886-94.
27. Furukawa H, Iwanaga T, Koyama H, Taniguchi H. Effect of sex hormones on carcinogenesis in the stomachs of rats. Cancer Res 1982;42:5181-2.
28. Rutqvist LE, Johansson H, Signomklao T, Johansson U, Fornander T, Wilking N. Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group. J Natl Cancer Inst 1995;87:645-51.
29. Grodstein F, Newcomb PA, Stampfer MJ. Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med 1999;106:574-82.
30. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, et al. Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 2004;350:991-1004.
31. Katzenellenbogen BS. Estrogen receptors: bioactivities and interactions with cell signaling pathways. Biol Reprod 1996;54:287-93.
32. Zhao XH, Gu SZ, Liu SX, Pan BR. Expression of estrogen receptor and estrogen receptor messenger RNA in gastric carcinoma tissues. World J Gastroenterol 2003;9:665-9.
33. Tokunaga A, Nishi K, Matsukura N, et al. Estrogen and progesterone receptors in gastric cancer. Cancer 1986;57:1376-9.
34. Pricci M, Linsalata M, Russo F, et al. Effects of 17β-estradiol administration on apoptosis and polyamirte content in AGS cell line. Anticancer Res 2001;21:3215-20.
35. Katoh M. Trefoil factors and human gastric cancer [review]. Int J Mol Med 2003;12:3-9.